Burning Rock Biotech annual ebitda
2018
2019
2020
2021
2022
2023
2024
2025
Burning Rock Biotech EBITDA Growth & History (BNR)
Burning Rock Biotech's calculated EBITDA was −¥33.1M for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −¥33.1M | ¥272.3M | — |
| 2024 | 2024-12-31 | −¥305.4M | ¥230.6M | — |
| 2023 | 2023-12-31 | −¥535.9M | ¥320.4M | — |
| 2022 | 2022-12-31 | −¥856.3M | −¥107.0M | — |
| 2021 | 2021-12-31 | −¥749.3M | −¥370.2M | — |
| 2020 | 2020-12-31 | −¥379.1M | −¥241.4M | — |
| 2019 | 2019-12-31 | −¥137.7M | −¥1.0M | — |
| 2018 | 2018-12-31 | −¥136.7M | — | — |
Burning Rock Biotech quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Burning Rock Biotech ebitda trends
Over the last five reported fiscal years, Burning Rock Biotech's ebitda increased from −¥379.1M to −¥33.1M, a change of ¥346.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech filings at SEC.gov ↗